John P. Leonard, MD^1*, Kathryn Kolibaba, MD², James A. Reeves, MD^3*, Anil Tulpule, MD⁴, Ian W. Flinn, MD, PhD⁵, Tatjana Kolevska, MD^6*, Robert Robles, MD⁷, Christopher Flowers, MD⁸, Robert Collins, MD⁹, Nicholas J. DiBella, MD^10*, Steven W. Papish, MD¹¹, Parameswaran Venugopal, MD^12*, Andrew Horodner, MD^13*, Amir Tabatabai, MD^14*, Julio Hajdenberg, MD^15*, George Mulligan, PhD^16*, Rachel Neuwirth, PhD^17*, Kaveri Suryanarayan^17*, Dixie-Lee Esseltine, MD¹⁷ and Sven de Vos, MD, PhD¹⁸

¹Weill Cornell Medical College, New York, NY
²Medical Oncology / Hematology, Compass Oncology, Vancouver, WA
³Florida Cancer Specialists, Fort Myers, FL
⁴Department of Medicine, Keck Medicine of University of Southern California, Los Angeles, CA
⁵Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN
⁶Medical Oncology, Kaiser Permanente Medical Center - Northern California, Vallejo, CA
⁷Hematology Oncology, Bay Area Cancer Research Group (Diablo Valley Medical Group), Pleasent Hill, CA
⁸Winship Cancer Institute of Emory University, Atlanta, GA
⁹University of Texas Southwestern Medical Center, Dallas, TX
¹⁰Rocky Mountain Cancer Center, Aurora, CO
¹¹Carol G. Simon Cancer Center, Morristown, NJ
¹²Rush Center for Clinical Studies, Chicago, IL
¹³Cancer Care Associates Medical Group, Redondo Beach, CA
¹⁴York Cancer Center / Cancer Care Associates of York, York, PA
¹⁵M.D. Anderson Orlando, Orlando, FL
¹⁶Takeda Pharmaceuticals, Inc., Cambridge, MA
¹⁷Millennium Pharmaceuticals, Inc., Cambridge, MA
¹⁸Jonsson Comprehensive Cancer Center, Los Angeles, CA

Andrew J Davies, MRCP PhD^1*, Josh Caddy^2*, Tom Maishman^2*, Sharon Barrans, PhD^3*, Christoph Mamot, MD^4*, Matthew Care, PhD^5*, Christopher Pocock⁶, Louise Stanton, PhD^2*, Debbie Hamid^2*, Keith Pugh, PhD^2*, Andrew McMillan, PhD⁷, Paul Fields, MD PhD⁸, Anton Kruger^9*, Andrew Jack, PhD, MB¹⁰ and Peter W.M. Johnson, FRCP¹

¹Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom
²Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
³St James Institute of Oncology, HMDS, Leeds, United Kingdom
⁴Kantonsspital Aarau AG, Aarau, Switzerland
⁵University of Leeds, Leeds Institute of Cancer and Pathology, Leeds, United Kingdom
⁶East Kent Hospitals, Canterbury, United Kingdom
⁷Nottingham City Hospital, Nottingham, United Kingdom
⁸Department of Haematology, Guy's and St Thomas' Hospitals NHS Trust, London, United Kingdom
⁹Royal Cornwall Hospital, Truro, United Kingdom
¹⁰HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Patrick B. Johnston, MD, PhD^1*, Betsy R. Laplant, MS^2*, Ellen D. McPhail, MD³, Thomas M. Habermann, MD¹, David J. Inwards, MD¹, Ivana N. Micallef, MD¹, Joseph P. Colgan, MD¹, Grzegorz S. Nowakowski, MD¹, Stephen Ansell, MD, PhD⁴ and Thomas E. Witzig, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN
³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN

Christopher A. Yasenchak, MD¹, Ahmad Halwani, MD², Ranjana Advani³, Stephen Ansell, MD, PhD⁴, Lihua Elizabeth Budde, MD, PhD⁵, John M. Burke, MD⁶, Charles M. Farber, MD, PhD⁷, Beata Holkova, MD⁸, Luis E. Fayad, MD⁹, Kathryn S. Kolibaba, MD¹⁰, Mark Knapp, MD¹¹, Martha Li, PhD^12*, Thomas J. Manley, MD¹², Dipti Patel-Donnelly, MD¹³, Mahesh Seetharam, MD¹⁴, Habte A. Yimer, MD¹⁵ and Nancy L Bartlett, MD¹⁶

¹Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR
²University of Utah Huntsman Cancer Institute, Salt Lake City, UT
³Stanford Cancer Center, Stanford, CA
⁴Mayo Clinic, Rochester, MN
⁵Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁶Rocky Mountain Cancer Centers/US Oncology Research, Aurora, CO
⁷Hematology-Oncology Associates of Northern New Jersey and Pennsylvania Carol G. Simon Cancer Center/US Oncology Research, Morristown, NJ
⁸Virginia Commonwealth University, Massey Cancer Center, Richmond, VA
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Compass Oncology/US Oncology Research, Vancouver, WA
¹¹Mid Ohio Oncology/Hematology, Inc., Columbus, OH
¹²Seattle Genetics, Inc., Bothell, WA
¹³Virginia Cancer Specialists/US Oncology Research, Fairfax, VA
¹⁴Arizona Oncoloby Associates/US Oncology Research, Phoenix, AZ
¹⁵Texas Oncology-Tyler/US Oncology Research, Tyler, TX
¹⁶Washington University School of Medicine, Saint Louis, MO

Mark S Hertzberg, MBBS PhD FRACP FRCPA^1,2, Maher K Gandhi, PhD FRACP FRCPath FRCP³, Belinda Butcher, BSc MBiostat PhD CMPP^4*, Ruth Columbus, BSc PhD^5*, John Taper, MBBS FRACP FRCPA^6*, Judith Trotman, MBChB⁷, Devinder Gill, MB FRCPath FRACP FRCPA⁸, Shir-Jing Ho, MBBS FRACP FRCPA^9*, Keith Fay, MBChB FRACP FRCPA¹⁰, Gavin Cull, MBBS DM FRACP FRCPA¹¹, Andrew P Grigg, MBBS MD¹², Geoff Chong, MBBS FRACP^13*, Ian D. Lewis, MBBS PhD FRACP FRCPA¹⁴, Sam Milliken, MBBS FRACP FRCPA^15*, William Renwick^16*, Uwe Hahn, MBBS FRACP FRCPA^17*, Robin Filshie, PhD FRACP FRCPA¹⁸, Anne-Marie Watson, MBBS FRACP FRCPA¹⁹, George Kannourakis, MD, PhD²⁰, Max Wolf, MBBS FRACP FRCPA²¹, Andrew Wirth, MBBS^22*, Pauline Therese Warburton, MBBS PhD FRACP FRCPA²³, Stephen Robert Larsen, MBBS PhD FRCPA FRACP²⁴, John F. Seymour, MBBS, PhD²⁵ and Rodney Hicks, MBBS FRACP^26*

¹Dept of Haematology, Prince of Wales Hospital, Randwick, Australia
²Dept of Haematology, Westmead Hospital, Westmead, Australia
³Diamantina Institute, Queensland Institute of Medical Research, Herston, QLD, Australia
⁴WriteSource Medical Pty Ltd, Lane Cove, Australia
⁵Peter MacCallum Cancer Centre, East Melbourne, Australia
⁶Nepean Hospital, Nepean, Australia
⁷Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
⁸Dept. of Haematology,Pathology Qld, Princess Alexandra Hospital, Brisbane, Australia
⁹Dept of Haematology, St George Hospital, Kogarah, Australia
¹⁰Department of Haematology, Royal North Shore Hospital, Sydney, Australia
¹¹Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
¹²Austin Health, Melbourne, Australia
¹³Austin Hospital, Heidelberg, Australia
¹⁴Dept of Haematology, Royal Adelaide Hospital, Adelaide, Australia
¹⁵Dept of Haematology, St. Vincent's Hospital, Sydney, Australia
¹⁶Western Health, St Albans, Australia
¹⁷Dept of Haematology, Queen Elizabeth Hospital, Adelaide, Australia
¹⁸Dept of Haematology, St. Vincent's Hospital Melbourne, Fitzroy, Australia
¹⁹Dept of Haematology, Liverpool Hospital, Liverpool, Australia
²⁰Ballarat Onc. & Hem. Services, Ballarat, Australia
²¹Dept of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia
²²Dept of Radiation, Peter MacCallum Cancer Centre, East Melbourne, Australia
²³Dept of Haematology, Wollongong Hospital, Wollongong, Australia
²⁴Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, Australia
²⁵Peter MacCallum Cancer Centre, Melbourne, Australia
²⁶Dept of Nuclear Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia

Ralf Ulrich Trappe, MD^1,2*, Daan Dierickx, MD PhD^3*, Heiner Zimmermann, MD, MB BChir^1*, Franck Morschhauser, MD^4*, Peter Mollee, MBBS, FRCPA, FRACP, MMSc⁵, Jan M Zaucha, MD, PhD⁶, Martin H. Dreyling, MD, PhD⁷, Ulrich Dührsen, MD⁸, Petra Reinke, MD^9*, Gregor Verhoef, MD, PhD³, Marion Subklewe, MD¹⁰, Andreas Hüttmann, MD⁸, Thomas Tousseyn, MD PhD^11*, Gilles A. Salles, MD, PhD¹², Volker Kliem, MD^13*, Corrado Tarella^14*, Eric W Van Den Neste, MD, PhD¹⁵, Ingeborg A Hauser, MD^16*, Olivier Gheysens, MD^17*, Iannis Anagnostopoulos, MD^18*, Veronique Leblond, MD¹⁹, Hanno Riess, MD^2* and Sylvain Choquet, MD^19*

¹Department of Hematology and Oncology, DIAKO Hospital Bremen, Bremen, Germany
²Department of Hematology and Oncology, Charité University Hospitals, Berlin, Germany
³Department of Hematology, University Hospitals Leuven, Leuven, Belgium
⁴Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France
⁵Dept. of Haematology,Pathology Qld, Princess Alexandra Hospital, Brisbane, Australia
⁶Department of Oncological Propedeutics, Medical University of Gdansk, Gdynia, Poland
⁷Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany
⁸Department of Hematology, University Hospital Essen, Essen, Germany
⁹Department of Nephrology and Intensive Care, Charité University Hospitals, Berlin, Germany
¹⁰Department of Internal Medicine III, Ludwig-Maximilians University of Munich, Munich, Germany
¹¹Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium
¹²Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
¹³Department of Internal Medicine/Nephrology, Nephrological Center Lower Saxony, Hann. Münden, Germany
¹⁴Divisione Universitaria di Ematologia, Torino, Italy
¹⁵Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
¹⁶Department of Internal Medicine III, J.W. Goethe University Hospital, Frankfurt/Main, Germany
¹⁷Nuclear Medicine & Molecular Imaging, Catholic University Leuven, Leuven, Belgium
¹⁸Department of Pathology, Charite University Hospitals Berlin, Berlin, Germany
¹⁹Department of Clinical Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France